The endothelial adherens junctions (AJs) consist of trans-oligomers of membrane spanning vascular endothelial (VE)-cadherin proteins, which bind ␤-catenin through their cytoplasmic domain. ␤-Catenin in turn binds ␣-catenin and connects the AJ complex with the actin cytoskeleton. We addressed the in vivo effects of loss of VE-cadherin interactions on lung vascular endothelial permeability and the role of specific Rho GTPase effectors in regulating the increase in permeability induced by AJ destabilization. We used cationic liposomes encapsulating the mutant of VE-cadherin lacking the extracellular domain (⌬EXD) to interfere with AJ assembly in mouse lung endothelial cells. We observed that lung vascular permeability (quantified as microvessel filtration coefficient [K f,c ]) was increased 5-fold in lungs expressing ⌬EXD. This did not occur to the same degree on expression of the VE-cadherin mutant, ⌬EXD⌬␤, lacking the ␤-cateninbinding site. The increased vascular permeability was the result of destabilization of VE-cadherin homotypic interaction induced by a shift in the binding of ␤-catenin from wild-type VE-cadherin to the expressed ⌬EXD mutant. Because ⌬EXD expression in endothelial cells activated the Rho GTPase Cdc42, we addressed its role in the mechanism of increased endothelial permeability induced by AJ destabilization. Coexpression of dominant-negative Cdc42 (N17Cdc42) prevented the increase in K f,c induced by ⌬EXD. This was attributed to inhibition of the association of ␣-catenin with the ⌬EXD-␤-catenin complex. The results demonstrate that Cdc42 regulates AJ permeability by controlling the binding of ␣-catenin with ␤-catenin and the consequent interaction of the VE-cadherin/catenin complex with the actin cytoskeleton. (Circ Res. 2006;98:73-80.) 
A dherens junctions (AJs) are dynamic structures mediating endothelial cell-cell adhesion 1 and thereby regulate endothelial barrier function and tissue fluid homeostasis. 2, 3 Endothelial cell adhesion to contiguous cells, forming the endothelial monolayer, is determined in part by the transmembrane protein vascular endothelial (VE)-cadherin, which forms homotypic adhesive interactions 2, 4 and binds 2 members of the catenin family of cytosolic proteins (␤ and ␥ catenins). 5 ␤-Catenin binds ␣-catenin and connects junctional cadherins with the actin cytoskeleton. Permeabilityincreasing mediators such as histamine and thrombin increase junctional permeability in part by inducing the disassembly of AJs. 6 -8 The end result is a shift in fluid and plasma proteins to the extravascular space and development of protein-rich tissue edema.
Phosphorylation of AJ proteins contributes to the mechanism of destabilization of AJs. 7 Studies showed that histamine induced the phosphorylation of VE-cadherin and ␤and ␥ -catenins within 60 sec consistent with the rapidly increased microvascular permeability secondary to the formation of 100 to 400 nm-wide interendothelial gaps. 8 It was also shown that thrombin-induced activation of PKC␣ regulated the phosphorylation of VE-cadherin and catenins and thereby contributed to disruption of AJs and the increase endothelial permeability. 9 Phosphatases such as protein tyrosine phosphatase VE-PTP may also regulate the phosphorylation of VEcadherin/catenin components 10 and thus AJ integrity.
In addition, Rho GTPases RhoA, Rac1, and Cdc42 are important in regulating AJ assembly. 11, 12 Inhibition of RhoA prevented both thrombin-and histamine-induced disassembly of AJs 13 and the increase in endothelial permeability. RhoA is also directly linked to AJs through p120 catenin, a Src substrate that binds to the juxta-membrane domain of VEcadherin. 14 Overexpression of p120 catenin led to inhibition of RhoA in a GDP dissociation inhibitor-like manner. 15 Upor downregulation of p120 catenin in endothelial cells influenced VE-cadherin levels in endothelial cells. 16 In addition, activation of Cdc42 and Rac1 regulated the post-Golgi transport of endothelial cadherin to the AJs. 17 Other studies showed that Cdc42 can signal the activation of actin polymerization at the plasma membrane leading to formation of filopodia 18 and thus contributing to assembly of AJs. 19 Cdc42 and Rac1 may also affect AJ function through their interactions with the scaffold protein IQGAP1. 20, 21 Although the role of IQGAP1 in regulating AJ assembly has not been studied in endothelial cells, it was shown to colocalize with members of the AJ complex in other cell types 21 and thus may be an important determinant of junctional permeability downstream of Cdc42 and Rac1.
In the present study, we addressed the role of Cdc42 in the mechanism of increased endothelial permeability. Studies were made in the mouse lung microcirculation, so that inferences could be drawn concerning the in vivo regulation of endothelial permeability. We used the VE-cadherin mutant lacking the extracellular domain (⌬EXD) and another mutant lacking both extracellular domain and cytosolic distal ␤-catenin-binding domain (⌬EXD⌬␤). 22 We tested the hypothesis that expression of ⌬EXD promotes a shift in the VEcadherin-bound ␤-catenin as well as ␣-catenin toward the expressed mutant and thus would destabilize AJs. Because studies have shown that expression of ⌬EXD in endothelial cells induced Cdc42 activation, 22 we also addressed whether destabilization of AJs secondary to the loss of VE-cadherin homotypic interaction increases endothelial permeability through a Cdc42-dependent mechanism. We observed an increase in lung microvascular permeability on ⌬EXD expression, which did not occur to the same degree with ⌬EXD⌬␤ expression. The increased endothelial permeability was the result of loss of normal VE-cadherin homotypic interaction induced by the binding of ␤-catenin and ␣-catenin to the expressed ⌬EXD mutant. We observed that coexpression of the dominant-negative (dn) Cdc42 mutant (N17Cdc42) significantly reduced the increase in lung vascular permeability induced by ⌬EXD. This was the result of preventing the association of ␣-catenin with the ⌬EXD-␤catenin complex. Thus, activation of Cdc42 plays an important role in the mechanism of ⌬EXD-induced AJ disruption and increased endothelial permeability by promoting the interaction of ␣-catenin with the ⌬EXD-␤-catenin complex.
Materials and Methods

VE-Cadherin and Rho GTPase Mutants
The plasmid vector pcDNA3 was cleaved at its multicloning site and specific cDNAs corresponding to truncated sequences of VEcadherin were inserted downstream of cytomegalovirus promoter. We constructed, as described, 22 a VE-cadherin mutant lacking the extracellular domain (⌬EXD) and a mutant lacking both the extracellular domain and cytosolic distal ␤-cateninbinding domain (⌬EXD⌬␤) ( Figure 1A) . Vector-control studies were performed with empty pcDNA3 plasmid vector (Invitrogen, Carlsbad, Calif). Cytomegalovirus-driven dominant active Cdc42 (V12), dnCdc42 (N17), Rac1 (N17), and RhoA (N19) plasmid DNAs were obtained from Drs Tohru Kozasa and Tatyana Voyno-Yasenetskaya (University of Illinois, Chicago).
Cell Culture and Transfection
HMEC-1 (Human Microvascular Endothelial Cells) and HPAEC (Human Pulmonary Artery Endothelial Cells) were grown 22 and Expression of these constructs did not affect expression of total VE-cadherin (140 kDa) and Cdc42 (23 kDa). C, Expression of ⌬EXD was also determined by immunofluorescence in lung endothelial cells isolated from liposome-⌬EXD cDNA-injected mice. Lung endothelial cells were obtained 24 hours after IV injection of constructs and stained for FLAG-⌬EXD with anti-FLAG (green) and anti-VE-cadherin (red) antibodies. Maximum expression was seen at this time period (bottom) (scaleϭ10 mol/L). Top, Control endothelial cells showing only VE-cadherin staining (scaleϭ20 mol/L). Results are representative of 4 experiments. transfected by electroporation as described in the online data supplement, available at http://circres.ahajournals.org.
Immunofluorescence and Confocal Microscopy
Endothelial cells were either seeded onto glass coverslips posttransfection and allowed to grow for 24 hours in complete medium or freshly obtained from collagenase-digested lungs and plated onto coverslips for 1.5 hour (described below). Cells were immunostained and visualized as described 23 in the online data supplement.
Preparation of Cationic Liposomes for In Vivo Studies
Liposomes composed of dimethyldioctadecyl ammonium bromide (Sigma) in a 1:1 molar ratio with cholesterol (Sigma) were prepared as described, 24 -28 except that the dried lipid film was resuspended in 5% dextrose in water and then sonicated for 20 minutes, followed by incubation at 42°C for 20 minutes and 0.45-m filtration. Liposomes were extruded through a 50-nm pore polycarbonate filter (Avestin). CD1 mice (Charles River, Wilmington, Mass), weighing 20 to 25 g, were injected IV with 50 g of plasmid DNA, which was mixed with 100 L of liposome suspension and allowed to equilibrate for 20 minutes before injection. Protein expression constructs was assessed 24 hours thereafter. All experimental procedures complied with Institutional and National Institutes of Health guidelines for animal use, and approvals were obtained from the Institutional Animal Care Committee.
Lung Endothelial Fractionization
CD1 mice were anesthetized 29 and excised lungs were perfused with Hanks' balanced salt solution through the pulmonary artery for 5 minutes, then with endothelial fractionation buffer (0.2% Triton X-100, 50 mmol/L Tris-Cl pH 7.9, 1ϫ Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktails 1 and 2, Sigma) at 0.5 mL/min for 30 sec. Eluate was collected from the left atrial cannula (200 L) for Western blotting, and remaining lung tissue was homogenized in tissue lysis buffer (1.5% Triton X-100, 0.1% sodium dodecyl sulfate, 0.5% dideoxycholate, 100 mmol/L phenylmethylsulfonyl fluoride, 1ϫ Protease Inhibitor Cocktail in PBS), followed by centrifugation at 3000g at 4°C for 10 minutes to remove insoluble material. Remaining lung tissue was compared with endothelial-rich lysate by Western blotting using endothelial cell markers (eg, angiotensinconverting enzyme, VE-cadherin). Endothelial-rich lysate stained strongly positive for endothelial antigens (data not shown); the purity of this lysate was 90%.
Isolation of Endothelial Cells by Collagenase Digestion of Mouse Lungs
To assess the expression of transfected proteins in endothelial cells, mice were euthanized 20 hours postinjection of liposome-DNA mixture. Lungs were perfused as above, diced into 2-mm cubes and transferred to 1% collagenase A (Roche)/Hanks' balanced salt solution (Gibco) and mixed at 37°C for 1 hour. Lung tissue was aspirated 10ϫ through a serological pipette and allowed to settle at room temperature. The supernatant was removed and centrifuged at 3000g for 1 minute. The supernatant was discarded, and cells were resuspended in modified EGM-2 endothelial cell medium (penicillin/ streptomycin instead of gentamicin/amphotericin B; Clonetics), and allowed to adhere to gelatinized coverslips for 1.5 hour. Cells were subsequently analyzed by immunofluorescence.
Pulmonary Microvascular Filtration Coefficient and Isogravimetric Lung Water Determinations
CD1 mice were anesthetized and lungs were removed, ventilated, and perfused ex vivo using our methods 2,29 to obtain stable pulmonary artery pressure (7 cm H 2 O) and lung wet weight over a minimum of a 90-minute period. Microvessel filtration coefficient (K f,c ) was measured by applying a 10 cm H 2 O brief step increase in left atrial pressure at 20 minutes postextraction (during the isogravimetric period). 2, 29 
Immunoprecipitation and Western Blotting
Cell and tissue lysates were subjected to immunoprecipitation and Western blotting as described in the online data supplement.
Cdc42 Activation Assay
Cdc42 activity was measured using the Cdc42 activation assay Biochem Kit (BK034, Cytoskeleton, Denver, Colo). Whole cell lysates were also analyzed for Cdc42 expression and total protein.
Data Analysis
Data were analyzed using the 2-tailed Student's t test as well as ANOVA. Values are reported as meanϮSEM. Values were considered significant at PϽ0.05. Densitometry measurements of Western blots were performed using the ImageJ program (NIH). Figure  1B ). Expression of FLAG-⌬EXD construct did not affect the expression of wild-type VE-cadherin and Cdc42. Figure 1C shows the expression of ⌬EXD in lung endothelial cells isolated from the liposome-DNA-injected mice. Lung endothelial cells were obtained 24 hours postinjection of construct and stained with anti-FLAG (green) and anti-VE-cadherin (red) antibodies. Maximum expression of ⌬EXD at the junctions seen at 24 hours was colocalized with the endogenous VE-cadherin (bottom) in contrast to control endothelial cells (top) ( Figure 1C ). Figure 2A shows results of confocal microscopy using anti-FLAG and anti-␤-catenin antibodies in the ⌬EXDexpressing (top) and ⌬EXD⌬␤-expressing (bottom) confluent HPAEC monolayers. ␤-Catenin was localized to the cell junctions. Expression of ⌬EXD caused the formation of numerous intercellular gaps and filopodia, whereas this did not occur with expression of ⌬EXD⌬␤ (Figure 2A ). Similar studies were performed in HMEC-1 cells (supplemental Figure I) . ⌬EXD, but not ⌬EXD⌬␤, colocalized with ␤-catenin. Figure 2B shows the results of anti-␤-catenin immunoprecipitation of HMEC lysates expressing ⌬EXD or ⌬EXD⌬␤ followed by immunoblotting. A decrease of total ␤-cateninbound VE-cadherin was observed on expression of ⌬EXD (25Ϯ5% decrease, second lane), but not with ⌬EXD⌬␤ (top, second and third lanes). ␤-Catenin interacted with ⌬EXD but not with ⌬EXD⌬␤ (third panel). The VEcadherin truncation mutants showed equal expression (bottom) and did not alter the endogenous VE-cadherin expression (fourth panel). Figure 2C shows inhibition of interaction of VE-cadherin with ␤-catenin following different levels of ⌬EXD expression. HMECs were transfected with 12 g or 6 g ⌬EXD cDNA (third and fourth lanes), and lysates were immunoprecipitated with anti-VE-cadherin antibody. Decrease in binding between VE-cadherin and ␤-catenin (bottom) in the presence of ⌬EXD was proportional to the level of expression of ⌬EXD (middle). The first lane shows immunoprecipitation with an isotype-matched control goat antibody.
Results
Expression of ⌬EXD in Junctions of Lung Endothelial Cells In Situ
Expression of ⌬EXD in Confluent Endothelial Cells Induces Junctional Destabilization
Cdc42 Regulates the Association of ␣-Catenin With VE-Cadherin
The top 2 panels of Figure 3A show results of immunoprecipitation of HMEC lysates with anti-FLAG antibody fol-lowed by immunoblotting with anti-␣-catenin or ␤-catenin monoclonal antibody (mAb). In ⌬EXD-expressing cells, both ␣and ␤-catenin were associated with ⌬EXD (second lane), but not with ⌬EXD⌬␤ (third lane) ( Figure 3A ). Coexpression of N17Cdc42 interfered with the association of ␣-catenin with ⌬EXD, whereas the association of ␤-catenin with ⌬EXD was unaffected (fourth lane) ( Figure 3A) . In contrast, coexpression of N19RhoA had no effect on the association of Figure 3A show expression of similar amounts of FLAG-tagged ⌬EXD or ⌬EXD⌬␤ (in second through fifth lanes) as well as similar expression of myc-tagged dnRhoA, dnCdc42, and endogenous VE-cadherin. Probing these immunoblots for the transfected myc-Cdc42 and myc-RhoA showed no interaction with the FLAG-⌬EXD construct (data not shown). Figure 3B shows the results of immunoprecipitation of lysates with ␤-catenin mAb followed by immunoblotting with anti-␣-catenin antibody. In ⌬EXD-expressing cells, we found increased ␣-catenin association with ␤-catenin (second lane) ( Figure 3B ). This failed to occur with the expression of ⌬EXD⌬␤ (third lane). Coexpression of N17Cdc42 with ⌬EXD prevented the increased association of ␣-catenin with ␤-catenin (fourth lane), whereas coexpression of N19RhoA had no effect on ␣-catenin association with ␤-catenin (fifth lane). Expression of ⌬EXD and Rho GTPases also had no effect on endogenous ␤-catenin expression (bottom 2 panels) ( Figure 3B ). Figure 4A shows results of Cdc42 GTPase activity. Expression of ⌬EXD increased the amount of activated Cdc42 (second lane), whereas coexpression of N17Cdc42 abrogated this response (fourth lane). N19RhoA had no effect on Cdc42 activity induced by ⌬EXD expression (fifth lane). Transfection of ⌬EXD⌬␤ also increased Cdc42 activity relative to control, but to a lesser degree than ⌬EXD (third lane). Total Cdc42 levels in the lysate were assessed using Western blotting ( Figure 4A, bottom) ; the upper band in Lane 3 represents the myc-tagged N17Cdc42. The expression of myc-tagged Cdc42 and RhoA was comparable ( Figure 4A) . Figure 4B shows the direct effect of Cdc42 activation and inhibition on the interaction between ␣-catenin and ␤-catenin. Expression of V12 dnCdc42 in endothelial cells increased this interaction (top, third lane), whereasN17 dnCdc42 decreased it by 75% (top, fourth lane). Immunoprecipitation with mouse nonspecific IgG did not immunoprecipitate ␣-catenin (first lane), and lysate levels of ␣-catenin and myc-Cdc42 constructs were comparable (second and third lanes, Figure 4B) . Figure 5A shows the gravimetric analysis of lungs obtained from mice expressing ⌬EXD and ⌬EXD⌬␤ mutants in lung endothelia. The ⌬EXD-expressing lungs became markedly edematous at 60 minutes postextraction in contrast to control lungs, which gained weight only at later time points ( Figure  5A ). This early weight increase is indicative of compromised endothelial barrier function. ⌬EXD⌬␤-expressing lungs were less edematous than ⌬EXD-expressing lungs such that the values between the 2 groups were different (PϽ0.05) at the time points shown. Figure 5B and 5C show that in ⌬EXD lungs the coexpression of N17Cdc42, in contrast to coexpression of N19RhoA, reduced the edema formation (PϽ0.05). Coexpression of N17Rac1 also failed to inhibit pulmonary edema (data not shown). Figure 5D shows K f,c measurements. Expression of ⌬EXD increased vascular permeability compared with control lungs (PϽ0.05). The increase in permeability was markedly less in the ⌬EXD⌬␤-expressing lungs relative to the expression of ⌬EXD (PϽ0.05). Coexpression of N17Cdc42, in contrast to coexpression of N19RhoA or N17Rac1, reduced the increase in vascular permeability seen in the ⌬EXD-expressing lungs (PϽ0.05). Expression of N17Cdc42 alone had no effect on basal pulmonary vascular permeability values ( Figure 5D ).
Cdc42-Dependent Increase in Lung Vascular Permeability Following ⌬EXD Expression
Discussion
We performed these studies to address the effects of destabilizing the VE-cadherin homotypic interaction by the in vivo . ⌬EXD⌬␤-expressing lungs were less edematous than ⌬EXD-expressing lungs at 70 to 90 minutes after initiation of perfusion ( †PϽ0.05; nϭ4). B, Coexpression of N17Cdc42, in contrast to N19RhoA, reduced edema formation in ⌬EXD-expressing lungs between 80 and 90 minutes (*PϽ0.05). Coexpression of N17Rac1 also failed to inhibit pulmonary edema at these time points (data not shown). C, Analysis of lung wet weight gain from A and B during the 60-to 90-minute perfusion period. Lungs transfected with ⌬EXD and ⌬EXDϩN19RhoA showed differences in rate of weight increase compared with ⌬EXD and ⌬EXDϩN17Cdc42 groups (**PϽ0.05). All values were different from control vector group (*PϽ0.05). D, Lung microvessel filtration coefficient (K f,c ). Expression of ⌬EXD, ⌬EXD⌬␤, and ⌬EXDϩN17Cdc42 increased K f,c compared with control lungs (*PϽ0.05; nϭ4 in each group). The increase in K f,c was less in ⌬EXD⌬␤-expressing lungs than in ⌬EXD-expressing lungs (**PϽ0.05). Coexpression of N17Cdc42, in contrast to N19RhoA or N17Rac1 ( ‡PϽ0.05), reduced the increase in K f,c seen in ⌬EXD-expressing lungs (**PϽ0.05, nϭ3 in each group). Expression of N17Cdc42 alone did not increase K f,c . All values are reported as meanϮSEM.
expression of the VE-cadherin cytoplasmic domain on lung vascular permeability and to determine the role of Rho GTPases in mediating the alterations in permeability. We showed that destabilization of VE-cadherin junctions induced by the expression of the VE-cadherin mutant, ⌬EXD, increased pulmonary vascular endothelial permeability in mice. Studies in confluent endothelial cells showed that expression of ⌬EXD resulted in the formation of intercellular gaps, indicating that the ⌬EXD competitively disrupted the normal VE-cadherin homotypic interactions, and thus increased vascular permeability. Previous studies have shown that cadherin proteins display a strong homophilic interaction in the presence of catenins bound to the cytoplasmic domain of cadherin. 30 We show herein that the ⌬EXD-expressing cells disrupted normal AJ assembly because of the redistribution of ␣and ␤-catenins away from the endogenous VE-cadherins localized at the AJs. This notion is supported by the finding that the expression of ⌬EXD promoted its association with ␣and ␤-catenins, whereas these effects were not observed after transfection of the ⌬EXD⌬␤ mutant lacking the ␤-cateninbinding domain.
Our mouse lung studies were performed using cationic liposomes to transduce the expression of the ⌬EXD mutant in lung vascular endothelial cells in vivo. We have shown that proteins are encoded in lung endothelial cells following the IV injection of the liposome-DNA complex. 25, 31 Using endothelial-rich fractions and endothelial cells obtained by collagenase digestion of mouse lungs, we demonstrated the expression of the FLAG-tagged ⌬EXD construct in endothelial cells. The expression of the ⌬EXD mutant was maximal at 24 hour after the liposome-DNA construct injection when all of the physiological measurements were made.
In studies using confluent endothelial cells, we observed that ⌬EXD colocalized with ␤-catenin at the plasma membrane. Expression of ⌬EXD caused widespread formation of intercellular gaps and filopodia, whereas these changes did not occur with the expression of ⌬EXD⌬␤. The impairment of normal VE-cadherin/catenin interactions induced by ⌬EXD likely interfered with AJ formation because of the loss of connection to the actin cytoskeleton through the ␤and ␣-catenins. 32 We observed a marked shift of ␤-catenin from native VE-cadherin to the expressed ⌬EXD mutant in support of this concept. In contrast, the expression of ⌬EXD⌬␤ had a less pronounced effect on lung vascular permeability compared with ⌬EXD. We noted that the transient transfection of ⌬EXD in the present study did not reduce endogenous VE-cadherin levels, an effect seen previously in studies using adenoviral transfection of a VE-cadherin mutant similar to ⌬EXD. 16 On stable transfection of ⌬EXD in HMEC-1 using a retroviral vector; however, we have also observed a decrease in endogenous VE-cadherin expression (data not shown). Taken together, these findings support the hypothesis that translocation of ␤-catenin from endogenous VE-cadherin to the expressed ⌬EXD mutant resulted in junctional instability and increased vascular permeability.
We have shown that expression of the ⌬EXD mutant in endothelial cells induces the specific activation of Cdc42 as compared with RhoA and Rac1 22 ; thus, we addressed the possibility that Cdc42 may be involved in regulating AJ disassembly induced by ⌬EXD expression. These experiments were made by cotransfecting dominant-negative mutants of Cdc42, RhoA, and Rac1 along with ⌬EXD. Our goal in using these constructs was to minimize the potential nonspecific effects of Rho GTPase-modifying reagents 33 and ensure the simultaneous delivery of both VE-cadherin and Rho GTPase constructs to assess protein-protein interactions and the role of Rho GTPases in mediating AJ disassembly. We identified an important role of Cdc42 in regulating the association of ␣-catenin with ␤-catenin following the binding of ␤-catenin to the expressed ⌬EXD. Strikingly, the coexpression of dnCdc42 (N17Cdc42) prevented the association of ␣-catenin with the ⌬EXD-␤-catenin complex, whereas dnRhoA or dnRac had no effect. In a study involving the immunoprecipitation of endothelial cell lysates with ␤-catenin mAb followed by immunoblotting with anti-␣catenin antibody, we observed that ⌬EXD expression induced the association of ␣with ␤-catenin, whereas this did not occur on expression of ⌬EXD⌬␤. The coexpression of dnCdc42 with ⌬EXD prevented the association of ␣-catenin with ␤-catenin; in contrast, coexpression of dnRhoA or dnRac had no effect on this association. Our findings demonstrate the key role of Cdc42 in regulating the binding of ␣-catenin to ⌬EXD-␤-catenin complex without altering the interaction of ␤-catenin to ⌬EXD. Thus, the mechanism of AJ instability induced by the Cdc42-mediated ␣-catenin association with the ⌬EXD-␤-catenin complex involves a shift of actin filaments from the endogenous VE-cadherin/ catenin complex to the expressed ⌬EXD.
The mutant ⌬EXD⌬␤ served as a useful control for ⌬EXD expression in these studies because it did not significantly disrupt AJs in endothelial cells. Additionally, the level of Cdc42 activation following ⌬EXD⌬␤ expression was significantly lower than ⌬EXD. We observed that ⌬EXD⌬␤ expression in the mouse lung increased vascular permeability, although the response was significantly attenuated compared with ⌬EXD. The basis of this diminished but persistent effect of ⌬EXD⌬␤ in increasing endothelial permeability is not clear, but it may be attributed to the reported interaction of ⌬EXD⌬␤ with p120 catenin, 22, 34 which could result in actin cytoskeletal rearrangement at the level of AJs 32, 35 and promote AJ alterations, albeit to a lesser degree than ⌬EXD.
We observed that the increase in vascular permeability following expression of ⌬EXD in mouse lung endothelial cells was attributed to Cdc42. Gravimetric analysis of lungs obtained from mice expressing the VE-cadherin mutants in lung endothelia showed that the ⌬EXD-expressing lungs became markedly edematous and coexpression of dnCdc42 significantly reduced both edema formation and increase in K f,c in these lungs. However, expression of dnCdc42 did not completely inhibit these effects of ⌬EXD, suggesting there may also be a Cdc42-independent effect on AJs. Another explanation for the incomplete inhibition of permeability is that dnCdc42 expression may not have fully blocked Cdc42 activity.
Although our results show that Cdc42 is involved in the mechanism of increased vascular permeability induced by the loss of homotypic VE-cadherin interactions, we cannot rule out the possibility that Cdc42 has additional other regulatory effects on endothelial barrier function. Our previous studies have shown that the reannealing of endothelial AJs occurring 1 to 2 hours following the thrombin-induced increase in permeability depends on Cdc42 activation. 23 These dual actions of Cdc42 (ie, promoting the binding of ␣-catenin to ␤-catenin shown in the present study and previously described reannealing of AJs 23, 36 ) suggest that Cdc42 activation regulates both AJ disassembly as well as reassembly. This concept is consistent with the versatility of Rho GTPases as effectors 37, 38 ; thus, the Cdc42-GTP "switch" may integrate both events depending on its spatial and temporal activation in the endothelial cell membrane. An important pathophysiological implication of our studies is that the Cdc42-mediated binding of ␣-catenin with ␤-catenin may serve to dampen the increase in endothelial permeability in response to inflammatory mediators.
